|
|
736 Center Street Lewiston, NY 14092 USA phone:716-754-2002 fax:716-754-2043
|
| Symbol |
LAMP |
| Exchange |
.PK |
| Founded |
1997 |
| Employees |
5 |
|
|
| www.lampharm.com
|
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| Wound healing and transdermally delivered drugs. |
 |
| Management |
| Joseph Slechta, President & CEO; Peter Rothbart, M.D., Treasurer; Elena Milantoni, Finance & Admin. |
|
|
|
|
| Keywords |
| woundwound, woundcare |
|
|
|
|
| Description |
|
L.A.M. Pharmaceutical, Corp. is a biomedical company focused on the development and commercialization of wound healing and transdermal drug delivery systems that offer patients, among other benefits, safer and more effective treatment for a variety of serious diseases. |
 |
| Products / Services |
IPM Wound Gel, has proven to be an effective treatment for minor abrasions and lacerations to leg, pressure and diabetic ulcers.
|
 |
| Technology / Differentiation |
| LAM's Ionic Polymer Matrix allows for the delivery of both drugs and therapeutic agents transdermally with the ability to control both time and level of delivery over a prolonged period of time. |
 |
| Market / Customers |
Its customers include wound care professionals and centers, doctors, nurses, hospitals, and individuals through the Internet
|
 |
| Strategy |
LAM Pharmaceutical Corporation has developed a network of global distribution partners with an emphasis on the emerging markets of Asia and Latin America.
LAM intends to seek out corporate alliances and co-marketing partnerships where other drugs and topical products can be enhanced by L.A.M. IPM technology.
|
 |
|
|
|
|